Illumina (NASDAQ: ILMN) director sold 1,500 shares under 10b5-1 plan
Rhea-AI Filing Summary
Illumina-related reporting person reported a sale of 1,500 shares of common stock on 05/28/2026 under a 10b5-1 plan, generating $225,150 in proceeds. The filing also lists 478 Restricted Stock Units and an Employee Stock Purchase Plan allocation of 500 shares.
Positive
- None.
Negative
- None.
Insights
Routine, pre-arranged insider sale disclosed under Section 144/10b5-1.
This filing shows a reported disposition of 1,500 shares on 05/28/2026 with proceeds of $225,150. The sale is described as executed pursuant to a 10b5-1 plan, indicating pre-arranged timing.
The cashflow treatment is attributable to the reporting person; remaining holdings include 478 RSUs and an ESPP allocation of 500 shares as listed. Timing and broader position context are limited to the excerpt; subsequent filings would show further position changes.